Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Tracing the natural and anthropogenic influence on the trace elemental chemistry of estuarine macroalgae and the implications for human consumption.

Ownsworth E, Selby D, Ottley CJ, Unsworth E, Raab A, Feldmann J, Sproson AD, Kuroda J, Faidutti C, Bücker P.

Sci Total Environ. 2019 May 21;685:259-272. doi: 10.1016/j.scitotenv.2019.05.263. [Epub ahead of print]

PMID:
31176213
2.

Identifying the ingredients of hydrous arc magmas: insights from Mt Lamington, Papua New Guinea.

Humphreys MCS, Zhang J, Cooper GF, Macpherson CG, Ottley CJ.

Philos Trans A Math Phys Eng Sci. 2019 Feb 25;377(2139):20180018. doi: 10.1098/rsta.2018.0018.

PMID:
30966932
3.

Mountain glaciation drives rapid oxidation of rock-bound organic carbon.

Horan K, Hilton RG, Selby D, Ottley CJ, Gröcke DR, Hicks M, Burton KW.

Sci Adv. 2017 Oct 4;3(10):e1701107. doi: 10.1126/sciadv.1701107. eCollection 2017 Oct.

4.

Highly saline fluids from a subducting slab as the source for fluid-rich diamonds.

Weiss Y, McNeill J, Pearson DG, Nowell GM, Ottley CJ.

Nature. 2015 Aug 20;524(7565):339-42. doi: 10.1038/nature14857.

PMID:
26289205
5.

Therapy-induced carboplatin-DNA adduct levels in human ovarian tumours in relation to assessment of adduct measurement in mouse tissues.

Jarvis IW, Meczes EL, Thomas HD, Edmondson RJ, Veal GJ, Boddy AV, Ottley CJ, Pearson DG, Tilby MJ.

Biochem Pharmacol. 2012 Jan 1;83(1):69-77. doi: 10.1016/j.bcp.2011.10.005. Epub 2011 Oct 14.

PMID:
22015635
6.

A Phase I clinical study of cisplatin-incorporated polymeric micelles (NC-6004) in patients with solid tumours.

Plummer R, Wilson RH, Calvert H, Boddy AV, Griffin M, Sludden J, Tilby MJ, Eatock M, Pearson DG, Ottley CJ, Matsumura Y, Kataoka K, Nishiya T.

Br J Cancer. 2011 Feb 15;104(4):593-8. doi: 10.1038/bjc.2011.6. Epub 2011 Feb 1.

7.

Curcumin ameliorates oxaliplatin-induced chemoresistance in HCT116 colorectal cancer cells in vitro and in vivo.

Howells LM, Sale S, Sriramareddy SN, Irving GR, Jones DJ, Ottley CJ, Pearson DG, Mann CD, Manson MM, Berry DP, Gescher A, Steward WP, Brown K.

Int J Cancer. 2011 Jul 15;129(2):476-86. doi: 10.1002/ijc.25670. Epub 2010 Nov 3.

8.

Cellular and molecular mechanisms for the synergistic cytotoxicity elicited by oxaliplatin and pemetrexed in colon cancer cell lines.

Nannizzi S, Veal GJ, Giovannetti E, Mey V, Ricciardi S, Ottley CJ, Del Tacca M, Danesi R.

Cancer Chemother Pharmacol. 2010 Aug;66(3):547-58. doi: 10.1007/s00280-009-1195-2. Epub 2009 Dec 18.

9.

Contribution of HIF-1 and drug penetrance to oxaliplatin resistance in hypoxic colorectal cancer cells.

Roberts DL, Williams KJ, Cowen RL, Barathova M, Eustace AJ, Brittain-Dissont S, Tilby MJ, Pearson DG, Ottley CJ, Stratford IJ, Dive C.

Br J Cancer. 2009 Oct 20;101(8):1290-7. doi: 10.1038/sj.bjc.6605311. Epub 2009 Sep 15.

10.

Quantitative analysis of trace element concentrations in some gem-quality diamonds.

McNeill J, Pearson DG, Klein-Bendavid O, Nowell GM, Ottley CJ, Chinn I.

J Phys Condens Matter. 2009 Sep 9;21(36):364207. doi: 10.1088/0953-8984/21/36/364207. Epub 2009 Aug 19.

PMID:
21832313
11.

The kinase inhibitor O6-cyclohexylmethylguanine (NU2058) potentiates the cytotoxicity of cisplatin by mechanisms that are independent of its effect upon CDK2.

Harrison LR, Ottley CJ, Pearson DG, Roche C, Wedge SR, Dolan ME, Newell DR, Tilby MJ.

Biochem Pharmacol. 2009 May 15;77(10):1586-92. doi: 10.1016/j.bcp.2009.02.018. Epub 2009 Mar 5.

PMID:
19426695
12.

Substituted beta-cyclodextrin and calix[4]arene as encapsulatory vehicles for platinum(II)-based DNA intercalators.

Krause-Heuer AM, Wheate NJ, Tilby MJ, Pearson DG, Ottley CJ, Aldrich-Wright JR.

Inorg Chem. 2008 Aug 4;47(15):6880-8. doi: 10.1021/ic800467c. Epub 2008 Jul 2.

PMID:
18597414
13.

Grain size partitioning of platinum-group elements in road-deposited sediments: implications for anthropogenic flux estimates from autocatalysts.

Sutherland RA, Graham Pearson D, Ottley CJ.

Environ Pollut. 2008 Feb;151(3):503-15. Epub 2007 Jun 7.

PMID:
17559994
14.

Specific adducts recognised by a monoclonal antibody against cisplatin-modified DNA.

Meczes EL, Azim-Araghi A, Ottley CJ, Pearson DG, Tilby MJ.

Biochem Pharmacol. 2005 Dec 5;70(12):1717-25. Epub 2005 Nov 2.

PMID:
16259963
15.

Expression of kinase-defective mutants of c-Src in human metastatic colon cancer cells decreases Bcl-xL and increases oxaliplatin- and Fas-induced apoptosis.

Griffiths GJ, Koh MY, Brunton VG, Cawthorne C, Reeves NA, Greaves M, Tilby MJ, Pearson DG, Ottley CJ, Workman P, Frame MC, Dive C.

J Biol Chem. 2004 Oct 29;279(44):46113-21. Epub 2004 Aug 23.

Supplemental Content

Loading ...
Support Center